Craft

Predictive Oncology

Stock Price

$0.8

2024-10-29

Market Capitalization

$5 M

2024-10-29

Revenue

$125.3 K

FY, 2025

Predictive Oncology Summary

Company Summary

Overview
Predictive Oncology (formerly Precision Therapeutics and Skyline Medical) is a medical device company. It provides an environmentally conscientious system for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. The company offers the STREAMWAY Fluid Waste Management System that suctions surgical waste fluid from the patient using standard surgical tubing. 
Type
Public
Status
Active
Founded
2002
HQ
Eagan, MN, US | view all locations
Website
https://predictive-oncology.com
Cybersecurity rating
Sectors

Key People

  • Carl Schwartz, Interim President and Cheif Executive Officer, Director

    • David Johnson, COO

      • Bob Myers, CFO

        • David Dauwalter, Director of Product Management

          LocationsView all

          1 location detected

          • Eagan, MN HQ

            United States

            2915 Commers Dr #900

          Predictive Oncology Financials

          Summary Financials

          Revenue (Q1, 2026)
          $35.3K
          Gross profit (Q1, 2026)
          ($3.4M)
          Net income (Q1, 2026)
          ($7.7M)
          Cash (Q1, 2026)
          $6.9M
          EBIT (Q1, 2026)
          ($7.7M)
          Enterprise value
          ($4.1M)

          Footer menu